Department of Dermatology, Medical University of Vienna, Vienna, SMZ Ost, 122, Langobardenstrasse, 1220, Vienna, Austria.
Department of Dermatology, Donauspital, SMZ Ost Vienna, Vienna, Austria.
Br J Dermatol. 2017 May;176(5):1155-1161. doi: 10.1111/bjd.15272. Epub 2017 Apr 5.
Photodynamic therapy (PDT) and chemical peels with trichloroacetic acid (TCA) can be applied to large skin areas and thus are suitable treatment options for patients with multiple actinic keratosis (AK). However, despite its long use, TCA has been investigated only rarely in this indication.
This randomized, observer-blinded, intrapatient comparative study sought to investigate the efficacy and safety of 35% TCA vs. aminolaevulinic acid 20% (ALA) PDT in patients with extensive field cancerization and multiple AKs in the face or on the scalp.
Twenty-eight patients with at least five AKs in two comparable anatomical areas on the head were treated with 35% TCA and ALA PDT randomly assigned to each area. Their therapeutic efficacy, adverse events and cosmetic outcome were assessed by a blinded investigator at 1, 3, 6 and 12 months after treatment.
After 12-months' follow-up TCA and ALA PDT reduced the total lesion count, the primary outcome, by 31% and 58%, respectively (P = 0·006). Complete clearance of pre-existing AKs were 49% for TCA and 74% for ALA PDT (P = 0·011). Treatment failure (number of AKs greater than 50% of the baseline count) was observed in seven patients (25%) after TCA and in two patients (7%) after PDT treatment. Treatment-related pain was significantly higher for ALA PDT (visual analogue scale 7·5 ± 2·3 vs. TCA: 5·1 ± 2·6; P = 0·04), whereas scarring (n = 6, 21%) was seen only in TCA treated patients.
ALA PDT provided better clinical results than TCA in the treatment of patients with extensive field cancerization and multiple AKs.
光动力疗法(PDT)和三氯乙酸(TCA)化学焕肤可用于大面积皮肤,因此是患有多发性光化性角化病(AK)患者的合适治疗选择。然而,尽管 TCA 已使用多年,但针对这种适应证,对其研究甚少。
本随机、观察者设盲、患者内比较研究旨在比较 35%TCA 与 20%氨基酮戊酸(ALA)PDT 治疗面部和头皮大面积光化性角化病和多发性 AK 的疗效和安全性。
28 例患者头部两个相似解剖区域均至少有 5 个 AK,随机将患者分为两组,分别接受 35%TCA 和 ALA PDT 治疗。治疗后 1、3、6 和 12 个月,由盲法研究者评估其疗效、不良反应和美容效果。
12 个月随访时,TCA 和 ALA PDT 分别使总皮损计数(主要结局)减少 31%和 58%(P=0.006)。TCA 和 ALA PDT 完全清除已存在 AK 的比例分别为 49%和 74%(P=0.011)。TCA 组有 7 例(25%)和 ALA PDT 组有 2 例(7%)患者治疗失败(AK 数量多于基线计数的 50%)。ALA PDT 治疗相关疼痛明显高于 TCA(视觉模拟评分 7.5±2.3 比 TCA:5.1±2.6;P=0.04),而 TCA 组仅 6 例(21%)患者出现瘢痕。
ALA PDT 治疗大面积光化性角化病和多发性 AK 的临床疗效优于 TCA。